COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.
Identifieur interne : 000895 ( 2020/Analysis ); précédent : 000894; suivant : 000896COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.
Auteurs : Kathleen A. Stringer [États-Unis] ; Michael A. Puskarich [États-Unis] ; Michael T. Kenes [États-Unis] ; Robert P. Dickson [États-Unis]Source :
- Pharmacotherapy [ 1875-9114 ] ; 2020.
Abstract
As the number of cases of COVID-19 (SARS-CoV-2) rise in the United States (US), the number of severe cases (those requiring ICU admission) rise with it. Initially, the estimate for severe cases was approximated at 5% based on experience from China.1, 2 However, the World Health Organization's (WHO) estimate from China for severe and critical cases is near 20% (Table).3 The primary clinical feature of COVID-19 is pneumonia, the severity of which directs the clinical course; it has been estimated that, of patients admitted to the ICU, up to half may require either invasive or non-invasive ventilatory support.4 This has created an unprecedented situation for emergency and critical care medicine.
DOI: 10.1002/phar.2394
PubMed: 32267979
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000283
- to stream PubMed, to step Curation: 000283
- to stream PubMed, to step Checkpoint: 000708
- to stream Ncbi, to step Merge: 003824
- to stream Ncbi, to step Curation: 003824
- to stream Ncbi, to step Checkpoint: 003824
- to stream Main, to step Merge: 000895
- to stream Main, to step Curation: 000895
- to stream Main, to step Exploration: 000895
- to stream 2020, to step Extraction: 000895
Links to Exploration step
pubmed:32267979Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.</title><author><name sortKey="Stringer, Kathleen A" sort="Stringer, Kathleen A" uniqKey="Stringer K" first="Kathleen A" last="Stringer">Kathleen A. Stringer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor</wicri:regionArea><wicri:noRegion>Ann Arbor</wicri:noRegion></affiliation></author><author><name sortKey="Puskarich, Michael A" sort="Puskarich, Michael A" uniqKey="Puskarich M" first="Michael A" last="Puskarich">Michael A. Puskarich</name><affiliation wicri:level="2"><nlm:affiliation>Department of Emergency Medicine, University of Minnesota, Minnesota, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Emergency Medicine, University of Minnesota, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Kenes, Michael T" sort="Kenes, Michael T" uniqKey="Kenes M" first="Michael T" last="Kenes">Michael T. Kenes</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor</wicri:regionArea><wicri:noRegion>Ann Arbor</wicri:noRegion></affiliation></author><author><name sortKey="Dickson, Robert P" sort="Dickson, Robert P" uniqKey="Dickson R" first="Robert P" last="Dickson">Robert P. Dickson</name><affiliation wicri:level="1"><nlm:affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, School of Medicine, Ann Arbor, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, School of Medicine, Ann Arbor</wicri:regionArea><wicri:noRegion>Ann Arbor</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32267979</idno><idno type="pmid">32267979</idno><idno type="doi">10.1002/phar.2394</idno><idno type="wicri:Area/PubMed/Corpus">000283</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000283</idno><idno type="wicri:Area/PubMed/Curation">000283</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000283</idno><idno type="wicri:Area/PubMed/Checkpoint">000708</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000708</idno><idno type="wicri:Area/Ncbi/Merge">003824</idno><idno type="wicri:Area/Ncbi/Curation">003824</idno><idno type="wicri:Area/Ncbi/Checkpoint">003824</idno><idno type="wicri:Area/Main/Merge">000895</idno><idno type="wicri:Area/Main/Curation">000895</idno><idno type="wicri:Area/Main/Exploration">000895</idno><idno type="wicri:Area/2020/Extraction">000895</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.</title><author><name sortKey="Stringer, Kathleen A" sort="Stringer, Kathleen A" uniqKey="Stringer K" first="Kathleen A" last="Stringer">Kathleen A. Stringer</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor</wicri:regionArea><wicri:noRegion>Ann Arbor</wicri:noRegion></affiliation></author><author><name sortKey="Puskarich, Michael A" sort="Puskarich, Michael A" uniqKey="Puskarich M" first="Michael A" last="Puskarich">Michael A. Puskarich</name><affiliation wicri:level="2"><nlm:affiliation>Department of Emergency Medicine, University of Minnesota, Minnesota, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Emergency Medicine, University of Minnesota, Minnesota</wicri:regionArea><placeName><region type="state">Minnesota</region></placeName></affiliation></author><author><name sortKey="Kenes, Michael T" sort="Kenes, Michael T" uniqKey="Kenes M" first="Michael T" last="Kenes">Michael T. Kenes</name><affiliation wicri:level="1"><nlm:affiliation>Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Department of Clinical Pharmacy, College of Pharmacy, Ann Arbor</wicri:regionArea><wicri:noRegion>Ann Arbor</wicri:noRegion></affiliation></author><author><name sortKey="Dickson, Robert P" sort="Dickson, Robert P" uniqKey="Dickson R" first="Robert P" last="Dickson">Robert P. Dickson</name><affiliation wicri:level="1"><nlm:affiliation>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, School of Medicine, Ann Arbor, United States.</nlm:affiliation><country xml:lang="fr">États-Unis</country><wicri:regionArea>Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, School of Medicine, Ann Arbor</wicri:regionArea><wicri:noRegion>Ann Arbor</wicri:noRegion></affiliation></author></analytic><series><title level="j">Pharmacotherapy</title><idno type="eISSN">1875-9114</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">As the number of cases of COVID-19 (SARS-CoV-2) rise in the United States (US), the number of severe cases (those requiring ICU admission) rise with it. Initially, the estimate for severe cases was approximated at 5% based on experience from China.<sup>1, 2</sup> However, the World Health Organization's (WHO) estimate from China for severe and critical cases is near 20% (Table).<sup>3</sup> The primary clinical feature of COVID-19 is pneumonia, the severity of which directs the clinical course; it has been estimated that, of patients admitted to the ICU, up to half may require either invasive or non-invasive ventilatory support.<sup>4</sup> This has created an unprecedented situation for emergency and critical care medicine.</div></front></TEI><affiliations><list><country><li>États-Unis</li></country><region><li>Minnesota</li></region></list><tree><country name="États-Unis"><noRegion><name sortKey="Stringer, Kathleen A" sort="Stringer, Kathleen A" uniqKey="Stringer K" first="Kathleen A" last="Stringer">Kathleen A. Stringer</name></noRegion><name sortKey="Dickson, Robert P" sort="Dickson, Robert P" uniqKey="Dickson R" first="Robert P" last="Dickson">Robert P. Dickson</name><name sortKey="Kenes, Michael T" sort="Kenes, Michael T" uniqKey="Kenes M" first="Michael T" last="Kenes">Michael T. Kenes</name><name sortKey="Puskarich, Michael A" sort="Puskarich, Michael A" uniqKey="Puskarich M" first="Michael A" last="Puskarich">Michael A. Puskarich</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/2020/Analysis
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000895 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd -nk 000895 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= 2020
|étape= Analysis
|type= RBID
|clé= pubmed:32267979
|texte= COVID-19: The Uninvited Guest in the Intensive Care Unit (ICU) Implications for Pharmacotherapy.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/2020/Analysis/RBID.i -Sk "pubmed:32267979" \
| HfdSelect -Kh $EXPLOR_AREA/Data/2020/Analysis/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |